Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 10/29/20
Due: 10/29/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma | NCT04317248 | Yuehua Huang | user2@example.com | None | 2020-04-01 | 2022-04-30 | 2023-04-30 | - | - | 2025-07-14 |
| A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT) | NCT03086564 | Yuehua Huang | user2@example.com | None | 2017-05-01 | 2020-10-29 | 2021-10-29 | - | - | 2025-07-14 |